Individualizing Mesothelioma Treatment: Small Steps Into a Brighter Future

Garland, Linda; Flores, Raja M.; Tsao, Anne S.

doi:10.3816/clc.2010.n.048

Cited by 4 publications

(3 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…5 The identification of prognostic determinants is, therefore, needed to stratify patients into distinct risk categories and optimize the provision of the currently available treatments, both in the radical and palliative setting. 6 A number of clinicopathologic features have been proven to predict prognosis in MPM. Sarcomatoid differentiation, elevated platelet and white blood cell (WBC) count, and more advanced performance status (PS) have been recognized to reflect a more aggressive disease course.…”

mentioning

confidence: 99%

Inflammation-Based Prognostic Indices in Malignant Pleural Mesothelioma

Pinato

Mauri

Ramakrishnan

et al. 2012

Journal of Thoracic Oncology

126

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 99%

Inflammation-Based Prognostic Indices in Malignant Pleural Mesothelioma

Pinato

Mauri

Ramakrishnan

et al. 2012

Journal of Thoracic Oncology

126

View full text Add to dashboard Cite

show abstract

“…En relación con la indicación de la pleurodesis, Tan et al 20 revisaron las indicaciones de este acto quirúrgico, el agente a utilizar y la técnica para efectuarla, así como los resultados obtenidos en los derrames pleurales malignos. Garland et al 21 consideran que la pleurodesis, la cirugía citorreductiva y la pleuroneumonectomía tienen como objetivo el control de los síntomas, alargar el tiempo de progresión y la posible curación del mesotelioma. NCT www.medigraphic.org.mx…”

Section: Discussionunclassified

Revisión del tratamiento y sobrevida del mesotelioma pleural maligno en el INER

Echegoyen-Carmona

Camacho-Mendoza

2015

NCT Neumología Y Cirugía De Tórax

View full text Add to dashboard Cite

“…The possibility of unrecognised exposure exists in other cases [3,4]. Although mesothelioma is an uncommon tumour, it is aggressive and resistant to treatment and is uniformly and rapidly fatal [5-7]. …”

Section: Introductionmentioning

confidence: 99%

OccIDEAS: An Innovative Tool to Assess Past Asbestos Exposure in the Australian Mesothelioma Registry

MacFarlane

Benke

Sim

et al. 2012

Safety and Health at Work

View full text Add to dashboard Cite

Malignant mesothelioma is an uncommon but rapidly fatal disease for which the principal aetiological agent is exposure to asbestos. Mesothelioma is of particular significance in Australia where asbestos use was very widespread from the 1950s until the 1980s. Exposure to asbestos includes occupational exposure associated with working with asbestos or in workplaces where asbestos is used and also 'take-home' exposure of family members of asbestos exposed workers. Asbestos exposure may also be non-occupational, occurring as a consequence of using asbestos products in non-occupational contexts and passive exposure is also possible, such as exposure to asbestos products in the built environment or proximity to an environmental source of exposure, for example an asbestos production plant. The extremely long latency period for this disease makes exposure assessment problematic in the context of a mesothelioma registry. OccIDEAS, a recently developed online tool for retrospective exposure assessment, has been adapted for use in the Australian Mesothelioma Registry (AMR) to enable systematic retrospective exposure assessment of consenting cases. Twelve occupational questionnaire modules and one non-occupational module have been developed for the AMR, which form the basis of structured interviews using OccIDEAS, which also stores collected data and provides a framework for generating metrics of exposure.

show abstract

Individualizing Mesothelioma Treatment: Small Steps Into a Brighter Future

Cited by 4 publications

References 23 publications

Inflammation-Based Prognostic Indices in Malignant Pleural Mesothelioma

Inflammation-Based Prognostic Indices in Malignant Pleural Mesothelioma

Revisión del tratamiento y sobrevida del mesotelioma pleural maligno en el INER

OccIDEAS: An Innovative Tool to Assess Past Asbestos Exposure in the Australian Mesothelioma Registry

Contact Info

Product

Resources

About